Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Thyrocare Technologies Ltd - 539871 - Board Meeting Intimation for To Approve Unaudited Stand-Alone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2021,

 Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to intimate that a meeting of our Board of Directors of the Company will be held on Thursday, August 12, 2021, to inter alia, consider and approve Unaudited Stand-alone and Consolidated Financial Results of the Company for the quarter ended June 30, 2021,
05-08-2021
Bigul

Thyrocare Technologies Ltd - 539871 - Disclosure Under Regulation 26(7) Of The Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 ('SEBI (SAST) Regulations')

 Disclosure under Regulation 26(7) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 ('SEBI (SAST) Regulations' and as required under Regulation 26(6) of the SEBI (SAST) Regulations, the board of directors of the Company constituted a committee of the four independent directors to provide reasoned recommendations on the Open Offer
05-08-2021
Bigul

Thyrocare Technologies Ltd - 539871 - Letter of Offer

 JM Financial Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer to the Public Shareholders of Thyrocare Technologies Ltd ("Target Company").
02-08-2021
Bigul

The charge of the young brigade from PharmEasy

 How friends from one zip code came together to build a unicorn that bought a listed company Thyrocare
01-08-2021
Bigul

Thyrocare Technologies Ltd - 539871 - Shareholding for the Period Ended June 30, 2021

 Thyrocare Technologies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here
21-07-2021
Bigul

Thyrocare Technologies Ltd - 539871 - Statement Of Investor Complaints For The Quarter Ended June 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- RAMJEE DORAIDesignation :- Company Secretary and Compliance Officer
16-07-2021
Bigul

AVM sir' has left the building

 It's an emotion packed exit for Thyrocare founder A Velumani who sold his pathlab chain to PharmEasy
04-07-2021
Bigul

Thyrocare Technologies Ltd - 539871 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Thyrocare Technologies Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
03-07-2021
Bigul

Thyrocare Technologies Ltd - 539871 - Updates on Open Offer

 JM Financial Ltd ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 3(1) and Regulation 4 read with Regulation 13(4), Regulation 14(3), Regulation 15(2) and other applicable Regulations of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, to the Public Shareholders of Thyrocare Technologies Ltd ("Target Company").
02-07-2021
Bigul

Thyrocare Technologies Ltd - 539871 - Closure of Trading Window

 This is to inform you that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, as amended, and in accordance with the Company's Code relating to prohibition of insider trading, the trading window of the Company will remain closed for trading in Company's equity shares for Directors / Designated Employees / Connected Persons covered by the said Code, with effect from July 01, 2021, and would be re-opened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the Quarter ended June 30, 2020..
30-06-2021
Next Page
Close

Let's Open Free Demat Account